HealthWarehouse.com Launches Application of Google Commerce Search for Prescription Medications

Consumers can quickly and accurately find thousands of medications

CINCINNATI, April 8, 2011 /PRNewswire/ -- HealthWarehouse.com, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, announced the implementation of Google's (Nasdaq: GOOG) Commerce Search to help customers find prescription medications on its US website.

"Many of our products are difficult to pronounce – let alone spell," explains Marston Alfred, Director of Product Development for HealthWarehouse.com.  "With our newly launched search, consumers can quickly and accurately find thousands of medications and their generic equivalents with the ease."

The newly launched search box powered by Google Commerce Search™  features:

  • Advanced spelling and auto completion for difficult to spell medications
  • Search results showing brand name and generic equivalents
  • Improved page speed performance and accuracy of search results
  • Machine learning and synonym suggestions

A link to the case study can be found on the official Google Blog at:

http://googleblog.blogspot.com/2011/03/google-commerce-search-30-you-wont.html

Google Commerce Search™ is a registered trademark of Google, Inc.

About HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc. (OTC: HEWA) is a trusted VIPPS accredited retail mail-order pharmacy based in Cincinnati, Ohio.  HealthWarehouse.com offers 300 prescription drugs for $3.50 with 100% FREE shipping and is a 2009 & 2010 winner of the BizRate Circle of Excellence Award for outstanding customer satisfaction and service. With a mission to provide affordable healthcare to every American by eliminating inefficiencies in the drug distribution chain, HealthWarehouse.com has become one of the fastest growing online pharmacies in the United States. HealthWarehouse.com is licensed in all 50 states and only sells drugs which are FDA-approved and legal for sale in the United States.  Visit HealthWarehouse.com online at http://www.HealthWarehouse.com.

SOURCE HealthWarehouse.com, Inc.

Suggested Articles

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

Patients receiving Bavencio actually did worse than those who got placebo, increasing the risk of death by 31%.

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.